256 related articles for article (PubMed ID: 31514068)
1. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
2. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
Pei CL; Fei KL; Yuan XY; Gong XJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
[TBL] [Abstract][Full Text] [Related]
6. LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating SRSF3.
Luo J; Gao K; Chen M; Tian B
Pathol Res Pract; 2022 Jun; 234():153905. PubMed ID: 35462226
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
[TBL] [Abstract][Full Text] [Related]
8. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
9. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
11. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.
Zhang J; Li WY; Yang Y; Yan LZ; Zhang SY; He J; Wang JX
Cell Cycle; 2019 Aug; 18(16):1882-1892. PubMed ID: 31208278
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Fang J; Sun CC; Gong C
Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
[TBL] [Abstract][Full Text] [Related]
16. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
17. LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
J Cell Physiol; 2020 Apr; 235(4):3939-3949. PubMed ID: 31595977
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
[TBL] [Abstract][Full Text] [Related]
19. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract][Full Text] [Related]
20. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]